Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS.

Rahavendran SV, Vekich S, Skor H, Batugo M, Nguyen L, Shetty B, Shen Z.

Bioanalysis. 2012 May;4(9):1077-95. doi: 10.4155/bio.12.85.

PMID:
22612688
2.

Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse model.

Yamazaki S, Nguyen L, Vekich S, Shen Z, Yin MJ, Mehta PP, Kung PP, Vicini P.

J Pharmacol Exp Ther. 2011 Sep;338(3):964-73. doi: 10.1124/jpet.111.181339. Epub 2011 Jun 16.

PMID:
21680888
3.

Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.

Yamazaki S, Skaptason J, Romero D, Vekich S, Jones HM, Tan W, Wilner KD, Koudriakova T.

Drug Metab Dispos. 2011 Mar;39(3):383-93. doi: 10.1124/dmd.110.035857. Epub 2010 Nov 23.

PMID:
21098644
4.

Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats.

Pollard RE, Broumas AR, Wisner ER, Vekich SV, Ferrara KW.

Ultrasound Med Biol. 2007 Feb;33(2):235-45.

PMID:
17306694
5.

Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit.

Cheng L, Rivero ME, Garcia CR, McDermott CD, Keefe KS, Wiley CA, Soules KA, Bergeron-Lynn G, Vekich S, Zhang K, Appelt K, Freeman WR.

J Ocul Pharmacol Ther. 2001 Jun;17(3):295-304.

PMID:
11436949
6.

Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase.

Acheampong AA, Chien DS, Lam S, Vekich S, Breau A, Usansky J, Harcourt D, Munk SA, Nguyen H, Garst M, Tang-Liu D.

Xenobiotica. 1996 Oct;26(10):1035-55.

PMID:
8905918

Supplemental Content

Loading ...
Support Center